During the past years, IL-15 has been considered one of the most promising cytokines in the treatment of cancer due to its ability to enhance the anti-tumoral response of CD8+ T and natural killer (NK) cells in pre-clinical studies (Klebanoff et al., 2004; Teague et al., 2006). The gene discussed is IL15; the disease is cancer.